Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users.
HIV-prevention measures specific to injection drug users (IDUs), such as opioid substitution treatment and needle-and-syringe programs, are not provided in many countries where injection drug use is endemic. We describe the incidence of diagnosed HIV infection in IDUs and the availability and coverage of opioid substitution and needle-and-syringe programs in the European Union and 5 middle- and high-income countries. Countries with greater provision of both prevention measures in 2000 to 2004 had lower incidence of diagnosed HIV infection in 2005 and 2006.
Wiessing
Lucas
L
European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal. Lucas.Wiessing@emcdda.europa.eu
Likatavicius
Giedrius
G
Klempová
Danica
D
Hedrich
Dagmar
D
Nardone
Anthony
A
Griffiths
Paul
P
D000701:Analgesics, Opioid / Q000627:therapeutic use; D003376:Counseling; D003431:Cross-Cultural Comparison; D019049:Developed Countries; D055030:Drug Users; D015658:HIV Infections / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D006291:Health Policy; D006297:Health Services Accessibility; D006801:Humans; D018671:Needle-Exchange Programs; D011314:Preventive Health Services; D015819:Substance Abuse, Intravenous / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy / Q000821:virology*
D000701:Analgesics, Opioid